How have you incorporated ctDNA into the clinical management of patients with gynecologic cancers?

ctDNA certainly is increasing rapidly in oncology and has been led by several other disease sites. I think right now, GYN oncology is figuring out how to incorporate this in our care to meaningfully impact our patients. I have not incorporated ctDNA in my practice routinely, but do see the role of i...

Potential COI: I am a speaker and consultant for Natera. I agree with Casey's points but would be cautious to reduce maintenance outside of a clinical trial situation, other than toxicity issues as he suggests. Treating asymptomatic disease recurrence is another great area for prospective study now ...